Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques. [electronic resource]
Producer: 20200316Description: 708-716 p. digitalISSN:- 1531-8257
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- Animals
- Antiparkinson Agents -- adverse effects
- Brain -- diagnostic imaging
- Dyskinesia, Drug-Induced -- drug therapy
- Levodopa -- adverse effects
- MPTP Poisoning -- drug therapy
- Macaca fascicularis
- Movement -- drug effects
- Parkinsonian Disorders -- chemically induced
- Piperidines -- pharmacology
- Positron-Emission Tomography
- Receptor, Muscarinic M2 -- metabolism
- Receptor, Serotonin, 5-HT1A -- metabolism
- Receptor, Serotonin, 5-HT2A -- metabolism
- Receptors, Adrenergic, alpha-2 -- metabolism
- Receptors, Dopamine D2 -- metabolism
- Receptors, Dopamine D3 -- metabolism
- Receptors, Histamine H3 -- metabolism
- Receptors, sigma -- metabolism
- Sigma-1 Receptor
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.